Frazier Life Sciences
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
Global
Return Model
Dilutive
Stage Focus
Seed to Public
Modality Focus
Therapeutics
Overview
Longstanding biotech investor with venture and public-market strategies across innovative therapeutics.
Portfolio and Signals
Relevant for clinical-stage or strongly differentiated platform companies that can fit a broader therapeutics story, including anti-infectives.
Access and Engagement
Access is standard biotech venture outreach via networks and syndicates.
Notable AMR Examples / Programs
Global biotech investing platform
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
